Delayed mechanism for induction of gamma-glutamylcysteine synthetase heavy subunit mRNA stability by oxidative stress involving p38 mitogen-activated protein kinase signaling.
Expression of the gamma-glutamylcysteine synthetase heavy subunit (gamma-GCSh), which encodes the rate-limiting enzymes for glutathione biosynthesis, is regulated by many cytotoxic agents. Moreover, gamma-GCSh mRNA expression is elevated in colorectal cancer, but how gamma-GCSh expression is regulated is not completely understood. By using actinomycin D, which inhibits new RNA synthesis, we showed that treatment of human colorectal cancer cells with the prooxidant sulindac increased the half-life of gamma-GCSh mRNA. By using a tetracycline-regulated gamma-GCSh mRNA assay system, we systematically dissected the cis-acting sequence and trans-acting factors that regulate the stability of gamma-GCSh by cytotoxic prooxidants. We demonstrated that a HuR recognition sequence, AUUUA, in the 3'-untranslated region is responsible for the decay of gamma-GCSh mRNA. Oxidative stress enhanced cytoplasmic content of HuR. Overexpression of HuR by transfection stabilized gamma-GCSh mRNA, whereas overexpression of a dominant-negative HuR mutant suppressed the induced stability. Furthermore, prooxidant-induced gamma-GCSh mRNA stabilization and HuR binding were blocked by p38 mitogen-activated protein kinase inhibitors. We provide the first evidence that reduction-oxidation regulation of gamma-GCSh expression, itself a reduction-oxidation sensor and regulator, is mediated at least in part by the p38 mitogen-activated protein kinase signaling through the HuR RNA-binding protein.
Song
Im-Sook
IS
Department of Molecular Pathology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Tatebe
Shigeru
S
Dai
Wenping
W
Kuo
M Tien
MT
D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D005721:Glutamate-Cysteine Ligase / Q000235:genetics*; D006207:Half-Life; D006801:Humans; D020935:MAP Kinase Signaling System / Q000502:physiology*; D016877:Oxidants / Q000633:toxicity; D018384:Oxidative Stress / Q000502:physiology*; D021122:Protein Subunits / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics*; D011994:Recombinant Proteins / Q000378:metabolism; D013467:Sulindac / Q000633:toxicity; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
D016877:Oxidants; D021122:Protein Subunits; D012333:RNA, Messenger; D011994:Recombinant Proteins; D013467:Sulindac; D048051:p38 Mitogen-Activated Protein Kinases; D005721:Glutamate-Cysteine Ligase